NCT00614224

Brief Summary

Aerobic treadmill exercise has been shown to improve walking, cardiovascular fitness and thereby risk factor profiles in chronic stroke patients (Macko et al., Stroke 2005). The proposed project is a randomized controlled trial in geriatric stroke patients with chronic disabilities to investigate potential mechanisms of treadmill therapy. The hypothesis is tested that 3-months of aerobic treadmill exercise induces structural brain plasticity and reorganization. The outcome measures are walking ability, gait pattern, cardiovascular fitness and brain morphology. This study will elucidate fundamental mechanisms of brain adaptations linked to task-repetitive aerobic lower extremity exercise. These mechanisms will not only lead to a better understanding but may also help to identify predictors of treatment response. 40 patients aged over 60 years with lower extremity paresis after a first-ever clinical stroke longer than 6 months prior to study inclusion will be recruited from: 1) The Geriatric Rehabilitation Clinic at the Robert-Bosch Hospital in Stuttgart 2) the Dept of Neurology, University Hospital in Tübingen. Subjects will be randomized to 3 months progressive graded aerobic treadmill exercise training (TAEX; 3 times/week, duration 10-45 min) or an attention control group (CON). Because we expect that localization and size of stroke affect therapy outcomes, stratified randomization will be used to balance entry into groups. We hypothesize that 3 months of treadmill gait training but not conventional care leads to improvements of cardiovascular fitness and gait and to brain reorganization (structural plasticity) in regions in which functional adaptations have been demonstrated using fMRI in previous studies. The specific aims are:

  • To assess reorganization by comparing cortical thickness, cortical density and fiber tract morphology before (time point 0), and after therapy (3 months) using T1-weighted 3D-MPRAGE images, voxel based morphometry and diffusion tensor imaging.
  • To correlate brain reorganization with improvements in walking velocity, and analysis of gait patterns (parameters, swing time, stance time, gait symmetry).
  • To correlate brain reorganization with location and size of the index stroke lesion and of diffuse white matter damage (subcortical vascular encephalopathy). Lesion and white matter damage will be evaluated based on T2-weighted FLAIR sequences.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Jan 2008

Typical duration for not_applicable stroke

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 31, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 13, 2008

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2010

Completed
Last Updated

May 28, 2015

Status Verified

January 1, 2008

Enrollment Period

2 years

First QC Date

January 31, 2008

Last Update Submit

May 27, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • aerobic capacity (peak VO2)

    Baseline (timepoint 0) and after training (3 months)

  • gait velocity

    Baseline (timepoint 0) and after training (3 months)

Secondary Outcomes (3)

  • cortical thickness (MRI)

    Baseline (timepoint 0) and after training (3 months)

  • grey matter density (VBM-MRI)

    Baseline (timepoint 0) and after training (3 months)

  • cerebrovascular reserve capacity (ASL-MRI)

    Baseline (timepoint 0) and after training (3 months)

Study Arms (2)

A

EXPERIMENTAL

Treadmill training group (TAEX)

Behavioral: treadmill exercise training

B

ACTIVE COMPARATOR

Attention control group (CON)

Behavioral: treadmill exercise training

Interventions

3 months (3 times/week) progressive graded aerobic treadmill training with a duration of 10-45 min per training session

AB

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women and men aged \> 60 years
  • first ever ischemic stroke at least prior 6 months
  • all conventional inpatient and outpatient physical therapy completed
  • residual hemiparetic gait disturbance adequate language and neurocognitive function to participate in exercise training and testing

You may not qualify if:

  • already performing \> 20 minutes aerobic exercise 3 X/ week
  • Alcohol consumption \>2 oz liquor, or 2x 4oz glasses of wine, or 2x 12 oz cans of beer per day.
  • Cardiac history of
  • unstable angina
  • recent (\< 3 months) myocardial infarction
  • congestive heart failure (NYHA category II)
  • hemodynamically significant valvular dysfunction.
  • Medical History:
  • recent hospitalization (\<3 months) for severe medical disease
  • symptomatic peripheral arterial occlusive disease
  • orthopedic or chronic pain conditions restricting exercise
  • pulmonary or renal failure
  • active cancer
  • poorly controlled hypertension (\>160/100) or diabetes mellitis (fasting glucose\>180 mg/dl, HbA1C \>10%)
  • Neurological history of
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

January 31, 2008

First Posted

February 13, 2008

Study Start

January 1, 2008

Primary Completion

January 1, 2010

Study Completion

April 1, 2010

Last Updated

May 28, 2015

Record last verified: 2008-01